Taunia Markvicka serves as Executive at Pacira Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Taunia Markvicka has executed 17 insider transactions totaling $4.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 28, 2021 involved receiving (via award) 100,000 shares valued at $0.
Taunia Markvicka currently holds 100,000 shares of Pacira Pharmaceuticals, Inc. (PCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Taunia Markvicka has been a net seller of PCRX stock. They have purchased $77.2K and sold $4.5M worth of shares.
Taunia Markvicka's most recent insider trade was on Sep 28, 2021, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.51 |
| Discretionary |
| Aug 25, 2016 | CRMD | $30.7K | Purchase | 18,600 | $1.65 | Discretionary |
| Jun 23, 2015 | CRMD | $19.2K | Purchase | 4,000 | $4.81 | Discretionary |
| Mar 17, 2015 | PCRX | $45.8K | Option Exercise | 8,349 | $5.49 | Discretionary |
| Nov 7, 2014 | PCRX | $19.9K | Purchase | 230 | $86.62 | Discretionary |
| Nov 6, 2013 | PCRX | $725.4K | Sale | 14,123 | $51.36 | Discretionary |
| Nov 6, 2013 | PCRX | $298.2K | Sale | 5,681 | $52.49 | Discretionary |
| Nov 6, 2013 | PCRX | $96.6K | Sale | 1,802 | $53.61 | Discretionary |
| Nov 6, 2013 | PCRX | $1.4M | Sale | 28,394 | $50.60 | Discretionary |
| Nov 6, 2013 | PCRX | $540.5K | Option Exercise | 50,000 | $10.81 | Discretionary |
| Sep 25, 2013 | PCRX | $54.9K | Option Exercise | 10,000 | $5.49 | Discretionary |
| Sep 25, 2013 | PCRX | $470.0K | Sale | 10,000 | $47.00 | Discretionary |
| Aug 14, 2013 | PCRX | $23.7K | Option Exercise | 14,700 | $1.61 | Discretionary |
| Aug 14, 2013 | PCRX | $543.9K | Sale | 14,700 | $37.00 | Discretionary |
| Jul 12, 2013 | PCRX | $952.1K | Sale | 29,754 | $32.00 | Discretionary |
| Jul 12, 2013 | PCRX | $47.9K | Option Exercise | 29,754 | $1.61 | Discretionary |